In mouse subcutaneous colon cancer models, this dual‐targeting hydrogel MS was found to induce local inflammation and immunogenic cell death of tumor cells, which increased both M1‐like TAMs and CD8+ T cells, leading to reshaping of the TME and inhibition of tumor invasion. This evidence concerns the gene CD8A and neoplasm.